Gottlieb: Branded Industry 'Gaming' Tactics Have Shifted From Regulatory To Commercial Space

 
• By Michael Cipriano

US FDA's focus on areas such as REMS abuse may have prompted certain brand sponsors to shift their focus to the commercial space to keep generic competition off the market, former commissioner Scott Gottlieb tells the Association for Accessible Medicines.

Scott Gottlieb
Scoot Gottlieb feels that the US FDA's efforts to stop certain brand firms from gaming the system to block generics have at least shifted the playing field even if they haven't eliminated the problem.

More from Generics

More from Biosimilars & Generics